GL1X · GenesisL1 explorer

MolNFT v1 · #98954 · protein

Crystal structure of a topoisomerase ATP inhibitor

4LP0 · Topoisomerase IV subunit B: “Crystal structure of a topoisomerase ATP inhibitor”. X-ray diffraction, 1 ligand (1YM), 1 pocket (best druggability 0.47). MolNFT v1 #98954 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4LP0
Type
protein
Length
192 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Topoisomerase IV subunit B
EC
5.99.1.-
UniProt
Q8DQB5
Ligands
1YM
Pockets
1 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATopoisomerase IV subunit B (EC 5.99.1.-)protein19231% helix, 30% strandQ8DQB5

Ligands and binding sites

  • 1YM · 6'-[(ethylcarbamoyl)amino]-4'-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-3,3'-bipyridine-5-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11070.470.80241YM

Compared structures

  • 4LP0 · Crystal structure of a topoisomerase ATP inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.